Long-term prognosis of MAFLD patients according to non-invasive methods easlfibronostg on June 26, 2026 Category: Publications Tag: Diabetes, LIVERFASt, MAFLD, MASLD, Monitoring, Screening Post navigation Previous: Previous post: Noninvasive LIVERFASt transition rate to liver fibrosis, similar to liver biopsy in NAFLD patientsNext: Next post: Comparison analysis of FIB-4, LIVERFASt, LSM in Sequential and Combinatory Pathways for NAFLD
